AVANIR Pharmaceuticals (NASDAQ:AVNR)
CAPS Rating:
A pharmaceutical company focused on developing, acquiring and commercializing novel therapeutic products for the treatment of chronic diseases.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No one has written a Pitch for AVNR yet. Tell us why you think AVNR will outperform or underperform the market.
RSS Headlines
Fool UK
